Acetylation of the Cd8 Locus by KAT6A Determines Memory T Cell Diversity  by Newman, Dane M. et al.
ArticleAcetylation of the Cd8 Locus by KAT6A Determines
Memory T Cell DiversityGraphical AbstractHighlightsd Loss of KAT6A during viral infection results in reduced cell
surface CD8 and TCR levels
d KAT6A acetylates histones of the Cd8 locus, specifically, the
promoter and E8I enhancer
d KAT6A deficiency results in reduced effector-like memory
CD8+ T cells
d Removal of the Cd8 E8I enhancer phenocopies KAT6A
removalNewman et al., 2016, Cell Reports 16, 3311–3321
September 20, 2016 ª 2016 The Author(s).
http://dx.doi.org/10.1016/j.celrep.2016.08.056Authors
Dane M. Newman, Shinya Sakaguchi,
Aaron Lun, ..., Wilfried Ellmeier,
Gabrielle T. Belz, Rhys S. Allan
Correspondence
belz@wehi.edu.au (G.T.B.),
rallan@wehi.edu.au (R.S.A.)
In Brief
Functionally distinct memory T cell
populations are generated during an
immune response, but how this occurs is
still unclear. Newman et al. show that
chromatin-mediated control of CD8 co-
receptor expression plays a critical role in
determining memory T cell diversity.Accession NumbersGSE85302
Cell Reports
ArticleAcetylation of the Cd8 Locus by KAT6A
Determines Memory T Cell Diversity
Dane M. Newman,1,2 Shinya Sakaguchi,4 Aaron Lun,1,2 Simon Preston,1,2 Marc Pellegrini,1,2 Kseniya Khamina,5
Andreas Bergthaler,5 Stephen L. Nutt,1,2 Gordon K. Smyth,1,2,3 Anne K. Voss,1,2 Tim Thomas,1,2 Wilfried Ellmeier,4
Gabrielle T. Belz,1,2,* and Rhys S. Allan1,2,6,*
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia
2Department of Medical Biology
3Department of Mathematics and Statistics
The University of Melbourne, Parkville, VIC 3010, Australia
4Division of Immunobiology, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna,
Vienna 1090, Austria
5CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria
6Lead Contact
*Correspondence: belz@wehi.edu.au (G.T.B.), rallan@wehi.edu.au (R.S.A.)
http://dx.doi.org/10.1016/j.celrep.2016.08.056SUMMARY
How functionally diverse populations of pathogen-
specific killer T cells are generated during an immune
response remains unclear. Here, we propose that
fine-tuning of CD8ab co-receptor levels via histone
acetylation plays a role in lineage fate. We show
that lysine acetyltransferase 6A (KAT6A) is respon-
sible for maintaining permissive Cd8 gene transcrip-
tion and enabling robust effector responses during
infection. KAT6A-deficient CD8+ T cells downregu-
lated surface CD8 co-receptor expression during
clonal expansion, a finding linked to reduced Cd8a
transcripts and histone-H3 lysine 9 acetylation of
the Cd8 locus. Loss of CD8 expression in KAT6A-
deficient T cells correlated with reduced TCR
signaling intensity and accelerated contraction of
the effector-like memory compartment, whereas
the long-lived memory compartment appeared unaf-
fected, a result phenocopied by the removal of the
Cd8 E8I enhancer element. These findings suggest
a direct role of CD8ab co-receptor expression and
histone acetylation in shaping functional diversity
within the cytotoxic T cell pool.
INTRODUCTION
Upon acute infection, antigen-specific CD8+ T cells become
activated and differentiate into cytotoxic effectors that aid in
the clearance of the pathogen. These activated CD8+ T cells pro-
liferate and develop into functionally distinct subsets consisting
of short-lived effector cells that die off shortly after the infection
is resolved and long-lived memory cells that persist (Harty and
Badovinac, 2008). Exactly how effector and memory cell fates
are generated during a primary response remains the subject
of intense investigation with transcriptional regulators (KaechCell Report
This is an open access article under the CC BY-Nand Cui, 2012), cell-to-cell interactions, co-stimulatory signals,
and inflammatory cytokines implicated in these fate decisions
(Arens and Schoenberger, 2010).
Mounting evidence also suggests that subtle qualitative and
quantitative differences in synapse formation between the
T cell receptor (TCR) and foreign peptide/major histocompatibil-
ity complex class I (pMHCI) play an important role in determining
effector/memory fate (Corse et al., 2011; Teixeiro et al., 2009;
Zehn et al., 2012). The CD8ab co-receptor is critical for support-
ing and enhancing TCR/pMHCI avidity, and small changes in
relative surface expression of CD8 can have potent effects on
overall TCR sensitivity and subsequent activation thresholds
(Feinerman et al., 2008; Laugel et al., 2011). Given that the tran-
scriptional and epigenetic regulation of the Cd8ab1 locus is also
highly dynamic and labile (Ellmeier et al., 2013; Harland et al.,
2014; Park et al., 2007), it is conceivable that heterogeneous
expression of CD8 proteins plays an important role in the tuning
of TCR signals and subsequent lineage fate determination.
Indeed, asymmetric division of CD8 proteins between first-gen-
eration daughter T cells led to separate effector and memory
fates of subsequent clones (Chang et al., 2007; King et al.,
2012). However, this mechanism has been refuted by a number
of groups (Buchholz et al., 2013; Gerlach et al., 2013; Hawkins
et al., 2013), and, as such, a direct link between the regulation
of heterogeneous CD8 co-receptor expression and T cell fate
has yet to be established.
During T cell development, Cd8a and Cd8b1 co-receptor
gene (Cd8) expression is controlled by the activity of five Cd8 en-
hancers (E8I–E8vi) (Ellmeier et al., 2013; Sakaguchi et al., 2015).
Previously, we have shown that the Cd8 enhancer E8I and Runx/
core-binding factor-b (CBFb) are critical for the maintenance
of CD8a expression during CD8+ T cell differentiation because
E8I, Runx3, or CBFb-deficient CD8
+ T cells downregulated
CD8a expression during activation (Hassan et al., 2011). This
finding correlated with loss of histone-H3 acetylation at the
Cd8a promoter in the absence of E8I, and the downregulation
of CD8a expression could be blocked by treatment with the his-
tone deacetylase inhibitor trichostatin A. This data suggesteds 16, 3311–3321, September 20, 2016 ª 2016 The Author(s). 3311
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
epigenetic programming of the Cd8a locus during T cell-activa-
tion-controlled CD8a expression (Hassan et al., 2011).
To further investigate this epigenetic programming, we have
examined how the loss of the histone acetyltransferase KAT6A
affected the generation of antiviral CD8+ T cell responses in vivo.
KAT6A, also known asMOZ orMYST3, is amember of theMYST
family of histone acetyltransferases and is essential for the long-
term repopulation of hematopoietic stem cells (Thomas et al.,
2006) and the formation of B cell memory (Good-Jacobson
et al., 2014), suggesting that it may play an important role in
T cell responses and memory development. In line with this,
KAT6A is highly expressed in thymus (Thomas et al., 2006)
and, along with other Myst family members, has been shown
to associate with Runx proteins (Yang and Ullah, 2007), which
may link these proteins to the activation of the CD8ab gene
cluster.
Here, we have discovered that KAT6A acetylates histones at
important regulatory regions of the Cd8 locus, allowing the
fine-tuning of CD8 co-receptor levels and TCR signaling inten-
sity. This, in turn, influences the lineage fate of the antiviral
T cell pool, a result that was phenocopied in cells lacking the
Cd8 E8I enhancer element. These findings suggest that histone
aceytlation of CD8 co-receptors plays a critical role in generating
CD8+ T cell diversity, and they reveal a mechanism regulating
lineage diversity during the immune response.
RESULTS
KAT6A Deficiency Results in Reduced LCMV-Specific
Effector-like Memory Cells
To examine the role of KAT6A in mediating the virus-specific
T cell response, we bred mice, in which exons 3 to 7 of the
Kat6a gene were flanked by loxP sites (Voss et al., 2009), to
mice expressing Cre recombinase under the control of lympho-
cyte-specific protein tyrosine kinase (Lck) to obtain a Kat6a con-
ditional knockout (Kat6acKO) (Figure S1A). Similar to previous
studies showing normal thymic T cell differentiation in KAT6A-
deficient mice (Thomas et al., 2006), no significant differences
in cell number or CD4 and CD8 co-receptor expression were
found in the thymus or peripheral T cell compartments in
Kat6acKO mice (Figures S1B and S1C).
Next, we investigated the importance of KAT6A in modulating
antiviral CD8+ T cell responses following infection with the lym-
phocytic choriomeningitis virus (LCMV)-WE strain that estab-
lishes an infection that is largely cleared from the host in the first
10 days. In order to standardize the TCR reactivity and also allow
for tracking of cells that may have downregulated CD8, we used
congenically marked Kat6acKO mice bearing the high-affinity
monoclonal P14 TCR specific for the LCMV (GP33)-specific
epitope (Pircher et al., 1989) (Kat6acKO P14). These cells and their
wild-type (WT) P14 counterparts were each adoptively trans-
ferred into separate CD45.1+CD45.2+ (F1) adoptive recipients.
Eight days after acute LCMV infection, there was no significant
difference between the total number of WT or Kat6acKO P14
CD8+ T cells recovered from the spleen (Figure 1A). However,
by day 60 post-infection, the total numbers of the residual
Kat6acKO P14 cell population had diminished considerably
when compared with the WT P14 population (Figure 1A).3312 Cell Reports 16, 3311–3321, September 20, 2016To understand the characteristics of the diminishing Kat6acKO
P14 cell population, we examined their differentiation into
effector and memory subpopulations based on relative expres-
sion of CD127 (interleukin-7 receptor-a; IL-7Ra) and killer cell
lectin-like receptor subfamily G member-1 (KLRG-1). Following
the peak of the immune response, populations of activated
CD8+ T cells that express KLRG-1 and are negative for CD127
represent an effector-like population and gradually die off
following viral clearance (Joshi et al., 2007; Obar et al., 2011).
Expanded populations that have upregulated CD127 but do
not express KLRG-1 are enriched in progeny that will go on to
form a long-lived memory T cell population (Joshi et al., 2007).
An additional subpopulation expresses both KLRG-1 and
CD127, although the functional role of this cohort is less well
defined (Obar et al., 2011). Although a small but significant
numerical increase in the Kat6acKO P14 KLRG-1+CD127+ popu-
lation was detected 8 days after infection, no significant differ-
ences were observed in the mean population sizes of KLRG-1+
CD127 or KLRG-1CD127+ compartments at this time point
(Figures 1B and 1C). Nevertheless, by day 60, the numbers of
both KLRG-1+CD127 and KLRG-1+CD127+ in Kat6acKO P14
populations had decreased markedly, a finding that was also
observed at day 170 after infection. In contrast, the total number
of KLRG-1CD127+ in the WT and Kat6acKO populations was
comparable at each time point. Interestingly, these day-60
KAT6A-deficient KLRG-1 cells also expanded in a manner
similar to that of WT in a recall response, suggesting that these
cells are bona fide memory (Figure 1D). Overall, these results
suggest that KAT6A may be dispensable for KLRG-1CD127+
formation and, instead, may be necessary for the enduring sur-
vival of the effector-like memory compartment.
Transcriptional Profiling of KAT6A-Deficient CD8+ T
Cells Reveals that the Epigenetically Repressed Cd8
Locus Is Associated with Downregulation of the
CD8ab-TCR Complex after Activation
To gain insight into the transcriptional basis of the altered immune
response of Kat6acKO P14 cells, we performed RNA sequencing
(RNA-seq) analysis on purified KLRG-1low and KLRG-1high CD8+
T cells derived from WT and Kat6acKO P14 donors obtained
from adoptive transfer experiments at day 8 after infection. Com-
parison ofWT andKat6acKO KLRG-1low populations revealed 206
differentially expressed (DE) genes (DE = adjusted p value <0.05)
(Figure 2A, left; TableS1), and272geneswereDE in an equivalent
comparison of KLRG-1high groups (Figure 2A, right; Table S2).
Although both DE gene lists were of limited explanatory value
for the observed impairment in Kat6acKO P14 effector-like mem-
ory populations (Tables S1 and S2), both KAT6A-deficient sub-
sets were found to have had significantly reduced (1.8–2.5 fold
change) transcription of Cd8a mRNA (Figure 2A). Since surface
expression of CD8a proteins is strictly required for concomitant
expression of CD8b (Gorman et al., 1988), transcriptional repres-
sion of Cd8a alone results in accompanying decreases of total
CD8ab heterodimer complex expression. Nevertheless, the loss
of Cd8a mRNA in Kat6acKO KLRG-1low cells was also accompa-
nied by significant decreases ofCd8b1mRNA (1.9 fold change),
suggestingmorecomprehensive repressionofCd8ab1 transcrip-
tion within this subset.
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Figure 1. Reduced Effector-like Memory T Cell Numbers Are
Observed in KAT6A-Deficient Mice after LCMV Infection
Congenically marked F1 recipient mice (CD45.1/2
+) were given either WT or
Kat6acKO naive CD8+Va2+CD45.2+ P14 T cells (5 3 104) and subsequently
infected with LCMV-WE.
(A) Quantification of mean number of donor CD45.2+ P14 T cells (±SEM)
recovered from spleen at days 8, 60, and 170 post-infection.
(B) Representative FACS plots of donor T cells recovered at indicated time
points post-infection. Subsets are defined as: KLRG-1+CD127, KLRG-1+
CD127+, and KLRG-1CD127+. Values are mean quadrant percentages
(±SEM) of the indicated subsets.
(C) Quantification of the mean number (±SEM) of each subset at indicated time
points post-infection.
(D) At day 60 post-infection, KLRG-1CD45.2+ P14 T cells were purified by
FACS and 5 3 104 cells transferred into naive hosts that were subsequently
infected with LCMV-WE. Data show quantification of themean number (±SEM)
of donor cells recovered from the spleen 8 days after infection.
Data in (A)–(C) are representative of three to four independent experiments
(n = 3–4 F1 recipients per donor per experiment). Data in (D) are from two in-
dependent donors. Significance was tested within and between groups by
paired or unpaired Student’s t tests, respectively. *p < 0.05; **p < 0.01; ***p <
0.001; ****p < 0.0001. Fold change is indicated for significant differences.Given these results, we examined whether the cell-surface
expression of CD8a and CD8b was reduced in Kat6acKO P14
T cells after infection. We found that, indeed, this was the
case at the peak of the acute response and remained so at 60
and 170 days post-infection (Figure 2B). Relative surface
expression of both CD8a and CD8b dimers was modestly
reduced on naive Kat6acKO P14 T cells (78%–80% of WT
mean fluorescence intensity [MFI]), albeit not to the extent of
activated cells (59%–65%). Relative surface expression of the
Va2 TCR chain, on the other hand, was unaltered in naive
Kat6acKO CD8+ P14 T cells but was reduced following activation
(73%–81% of WT P14 MFI), suggesting that TCR destabilization
was secondary to the loss of CD8 co-receptor expression. How-
ever, the surface expression of CD44, a marker of antigen expe-
rience that is structurally independent of the TCR, was unaltered
or moderately enhanced in KAT6A-deficient cells, indicating that
surface protein dysfunction on Kat6acKO P14 cells affects the
TCR but not all cell-surface proteins in general (Figure 2B).
Importantly, these results were also observed at the peak of
the polyclonal LCMV GP33-specific CD8+ T cell response (Fig-
ure S1D). These data suggest that KAT6A-mediated expression
of CD8 co-receptors has a negligible effect on the accumulation
of LCMV-specific CD8+ T cells during the acute response but
may be critical for the long-term endurance of the expanded
memory population.
To determine whether reduced CD8ab co-receptor expres-
sion on Kat6acKO P14 cells was associated with the observed
attenuation of the KLRG-1+ compartment, we gated on CD8ahigh
and CD8alow P14 cells (WT and Kat6acKO) and compared the
relative proportions of each gated subpopulation (Figure 3A).
Overall proportions of KLRG-1+CD127 were comparable be-
tween the CD8ahigh WT and Kat6acKO P14 populations 8 days
after infection, yet the proportion of KLRG-1+CD127 in the
CD8alow P14 populations was markedly lower at this time point,
even for WT P14 cells. Instead, both CD8alow P14 populations
displayed a significantly greater representation of KLRG-1
CD127+, with Kat6acKO cells at this time point also appearingCell Reports 16, 3311–3321, September 20, 2016 3313
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Figure 2. Transcriptional Profiling of KAT6A-Deficient CD8+ T Cells Reveals Epigenetically Repressed Cd8 Locus Is Associated with
CD8ab-TCR Complex Downregulation after Activation
(A) Donor WT and Kat6acKO P14 T cell populations at day 8 post-infection were purified into KLRG-1high of KLRG-1low subsets, and RNA-seq was performed.
Cell-subset comparisons of mRNA read count data indicating the relative fold change and average expression of 478 genes found to be differentially
(legend continued on next page)
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skewed toward a KLRG-1+CD127+ phenotype, particularly the
CD8high constituents. Phenotypic divisions at later time points
(days 60 and 170 after infection) also reflected a bias of CD8low
cells toward KLRG-1CD127+, particularly in the Kat6a-
deficient populations. Taken together, reduced CD8ab co-re-
ceptor expression on activated Kat6acKO P14 cells was strongly
correlated with altered phenotypic compositions at the peak
of the immune response (day 8; Figure 3A), which becomes
increasingly perceptible upon contraction of the expanded cell
pool (Figure 3A).
Previous studies have shown that KAT6A is required for H3K9
acetylation and transcriptional activity of key developmental
genes (Voss et al., 2009, 2012). This correlates our previous
data showing that the ablation of the Cd8 enhancer cis-regula-
tory element E8I (Hassan et al., 2011) resulted in the activation-
dependent downregulation of surface CD8ab expression, which
coincided with reduced H3ac of the Cd8a promoter. Similarly,
we found that the levels of H3K9ac in KLRG-1low KAT6A-defi-
cient P14 populations were significantly reduced across the
Cd8a promoter in comparison to their WT P14 counterparts (Fig-
ure 3B). Notably, localized H3K9ac enrichment within the E8I cis-
regulatory element was markedly reduced in both Kat6acKO
KLRG-1CD127+ and KLRG-1+CD127.
To explore potential changes in transcriptional networks oper-
ating in Kat6acKO CD8+ P14 T cells at day 8 after infection, we
used a list of 91 genes with known roles in T lymphocyte biology
(Table S3; modified from Arsenio et al., 2014) and examined
global expression of these genes via principal-component anal-
ysis (Figure S2A). Clustering of the four subsets suggests that the
transcriptional profile of Kat6acKO KLRG-1high populations was
intermediate of those of the WT KLRG-1high and WT KLRG-1low
populations, whereas the Kat6acKO KLRG-1low populations
were least similar to both WT and Kat6acKO KLRG-1high popula-
tions. This move of the Kat6acKO population away from the WT
KLRG-1+CD127-associated cluster represents a shift toward
a transcriptional KLRG-1CD127+ bias in the KAT6A-deficient
populations. An ANOVA of DE genes from genome-wide RNA
expression data further confirmed that the transcriptional profile
of theKat6acKO KLRG-1high population is intermediate of those of
both the WT population (p = 6.7 3 1016) and the Kat6acKO
KLRG-1low population, which is least comparable to the WT
KLRG-1high profile (p < 10100) (Figure S2B). Collectively,
comparative transcriptional profiling suggested an inherent
bias toward the KLRG-1CD127+ lineage in both Kat6acKO
subsets.
Destabilization of CD8-TCR Complex in KAT6A-
Deficient T Cells Results in Weakened Antigen-Specific
Tetramer Avidity and TCR Signaling Intensity
Variations in TCR ligand strength are known to have direct ef-
fects on the characteristics and intensity of downstream
signaling pathways and the subsequent diversification of cyto-expressed (DE = adjusted p value <0.05; colored dots) between WT and Kat6acK
indicated.
(B) Relative cell-surface expression levels of CD8a, CD8b, Va2, and CD44 of naive
determined by flow cytometry. Mean fluorescence intensity (MFI) profiles of these
quantified. MFI values for each donor population were normalized as a proportiotoxic T cell lineages (Corse et al., 2011; Teixeiro et al., 2009;
Zehn et al., 2012). Moreover, the CD8 co-receptors are known
to be important for stable TCR-MHCI (major histocompatibility
complex class I) interactions (Luescher et al., 1995; Norment
et al., 1988; Wooldridge et al., 2005). Thus, we sought to explore
potential modifications of TCR ligand-binding properties and
TCR-mediated signaling in Kat6acKO P14 cells. In accordance
with decreased Va2 and CD8ab expression, ex vivo tetramer-
binding capacity of the LCMV-specific Db/GP33-41 epitope
was significantly reduced in Kat6acKO P14 cells at day 8 and
day 60 after infection (Figure 4A). Loss of tetramer-binding
strength was mirrored by the decreased surface expression of
CD5, a highly sensitive marker of TCR reactivity and signaling in-
tensity (Azzam et al., 1998) (Figure 4A). Furthermore, the extent
of CD5 downregulation in Kat6acKO donor T cells was similar
across all phenotypic subsets in comparison to WT equivalents
(Figure 4B). These data suggest that the loss of CD8 expression
in KAT6A-deficient T cells was strongly correlated with weak-
ened TCR reactivity that may eventually compromise longer
term survival or ‘‘fitness’’ of these cells (Gett et al., 2003).
Loss of Cd8 E8I Also Results in Diminished Effector-like
Memory T Cell Development
Finally, we designed an experiment to specifically address how
altering the level of the CD8 co-receptors during viral infection
affected T cell fate. To this end, we analyzed the CD8+ T cell
response of mice deficient for the E8I enhancer element known
only to be active in mature CD8 single-positive thymocytes, in
CD8+ T cells, and in innate-like CD8aa+ intraepithelial lympho-
cytes (Ellmeier et al., 1997; Hostert et al., 1997). Previously, we
and others have shown that E8I-deficient CD8
+ T cells are unable
to maintain CD8ab expression upon activation, akin to that of the
KAT6A deficiency (Chandele and Kaech, 2005; Hassan et al.,
2011). As expected, 8 days after infection, we observed a strong
downregulation of CD8a expression on antigen-specific T cells
in the E8I knockout mice compared to their WT counterparts
(Figure 5A) and little alteration in the numbers or phenotype
of the responding cells (Figure S3A). However, 35 days after
infection, we observed a substantial reduction in the number
of E8I-deficient GP33
+ cells that was due to a selective loss
of effector-like KLRG-1+CD127 and KLRG-1+CD127+, but not
KLRG-1CD127+, similar to that observed in Kat6a deficiency
(Figure 5B, upper panels). This result was also confirmed using
CD62L as another marker of memory populations (Figure 5B
lower panels). Overall, these data suggest that the maintenance
of CD8ab co-receptor levels plays a critical role in guiding the
development of specific T cell populations.
DISCUSSION
Previously, it has been shown that cells separated on their level
of CD8 during the early immune response had distinct cell fates,O (refer to Tables S1 and S2 for detailed lists of DE genes). Cd8ab1 genes are
or activated donor T cell populations at indicated time points post-infection as
cell-surface proteins fromWT and Kat6acKO donor P14 T cell populations were
n of the mean WT MFI for each experiment.
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Figure 3. Downregulation of CD8a in Kat6acKOMice Is Associated with Long-Lived Memory T Cell Bias and Loss of Acetylation of the CD8a
Locus
Congenically marked F1 recipient mice (CD45.1/2
+) were given either WT or Kat6acKO naive CD8+Va2+CD45.2+ P14 T cells (5 3 104) and subsequently infected
with LCMV-WE.
(A) Gating strategy of CD8ahigh and CD8alow donor T cells (left) and the mean proportion (±SEM) of each gated population exhibiting the indicated phenotype at
indicated time points post-infection (right). All infection data are representative of three to four independent experiments (n = 3–4 F1 recipients per donor per
experiment).Significancewas testedwithinandbetweengroupsbypairedorunpairedStudent’s t tests, respectively. Foldchange indicated for significantdifferences.
(B) Comparative levels of H3K9 acetylation of keyCd8 loci andGapdh promoter control regions from each donor T cell subset as determined byChIP and qPCR at
day 8 after infection. Graphs show the mean percentage of input MFI (±SEM).
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, not significant.
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Figure 4. Destabilization of CD8-TCR Complex Results in Weakened Antigen-Specific Tetramer Avidity and TCR Signaling Intensity
(A) Relative binding avidity of APC-labeled LCMV-specific Db/GP33-41 tetramer and CD5 expression on the surfaces of CD45.2+CD45.1 donor CD8+ P14 T cells
at day 0 (naive), day 8, and day 60 post-infection. Quantification of mean aggregate MFIs of donor populations (normalized to mean WT MFI) (dot plots, right).
(B) Relative CD5MFIs of various donor T cell subsets at day 8 and day 60 after infection. MFI values for each donor population were normalized as a proportion of
the mean WT MFI of each experiment. Data shown are of two independent experiments comprising n = 6 recipients at each time point.with cells that expressed higher levels of CD8 developing into
effector-like memory (Chang et al., 2007; King et al., 2012). How-
ever, this work was performed in the context of the asymmetric
distribution of CD8a, which has been not been universally
accepted as a mechanism that drives lineage-fate choice (Buch-
holz et al., 2013; Gerlach et al., 2013; Hawkins et al., 2013). Here,
we propose an entirely different mechanism for the regulation of
CD8 expression levels and memory T cell diversification. We
found that histone acetylation at the Cd8 locus by KAT6A is crit-
ical for sustaining CD8-mediated TCR avidity and signaling
above the threshold necessary for robust effector T cell forma-
tion and persistence.
Based on our data, the relative degree to which CD8 was
downregulated following primary activation (Xiao et al., 2007)
appears to strongly dictate the potential of cells to engage
either terminal effector (CD8high, KLRG-1+CD127) or memory
(CD8low, KLRG-1CD127+) transcriptional pathways. However,
in the absence of KAT6A, this activation-induced loss of CD8expression was magnified, thereby decreasing the avidity of
subsequent TCR:pMHCI interactions and altering the down-
stream signaling profiles of proliferating T cells. The resulting dis-
ruptions to TCR-mediated signaling appeared to destabilize the
integrity of the effector-like memory compartment and skew the
Kat6acKO T cell populations toward a CD8low, KLRG-1CD127+
memory lineage pathway. The result of KAT6A loss is reminis-
cent of the memory generated in response to low-affinity altered
peptide ligands (Zehn et al., 2009), large precursor frequency
(Marzo et al., 2005), or with anti-inflammatory cytokines such
as interleukin (IL)-10 or IL-21 (Cui et al., 2011), which all reduce
TCR activation and promote the generation of long-lived
memory T cells.
Although the downregulation of CD8ab was the most striking
feature of KAT6A-deficient cells, we cannot exclude that this
enzyme also targets regions other than the Cd8 locus and that
this contributes to the memory phenotype we observed. In order
to address this concern, however,weshowed that the lossof onlyCell Reports 16, 3311–3321, September 20, 2016 3317
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Figure 5. Loss of an Enhancer that Regulates CD8 Expression Results in Diminished Effector-like Memory Development
E8I KO and WT mice were infected with LCMV-WE and the presence of antigen-specific (D
bGP33-tetramer+) T cells was analyzed.
(A) Representative flow cytometry plots showing the level of CD8a on naive TCRb+CD4 T cells or TCRb+CD4CD44+GP33+ T cell populations 8 days after
infection.
(B) Quantification of the mean (±SEM) T cell number recovered from spleen at day 35 post-infection (left panel). Quantification of each T cell subset as defined by
KLRG-1 and CD127 (upper panel) or KLRG-1 and CD62L (lower panel). All data are representative of two independent experiments (n = 3–4 per experiment).
*p < 0.05; **p < 0.01; ns, not significant.theCd8 E8I enhancer element mirrored KAT6A deficiency, which
validated our hypothesis of CD8 levels playing a direct role in line-
age diversification. This is also in line with our previous work,
which reported that E8I and histone acetylation are required to
promote the Cd8a transcription during TCR activation (Hassan
et al., 2011), and we now implicate KAT6A in this process.
Our results and data from previously published studies sug-
gest that there may be two mechanisms that lead to memory
generation: an effector-based memory differentiation process,
which depends on KAT6A function (shown here) and E8I (Mada-
kamutil et al., 2004), and memory that is generated under
reduced activation conditions, which is independent of KAT6A
function or E8I (Chandele and Kaech, 2005). Both memory differ-
entiation processes are active in vivo, as was previously demon-
strated (Huang et al., 2011) and also supported by the data pre-
sented here. KAT6A distinguishes these two processes, where
the absence of KAT6A-mediated acetylation of the Cd8a locus3318 Cell Reports 16, 3311–3321, September 20, 2016(and Cd8a transcription) drives downregulation of CD8ab
expression, resulting in reduced TCR signaling that leads to
the survival of memory precursor cells that maintain recall ca-
pacity. In contrast KAT6A-mediated acetylation of E8I is required
forCd8a transcription during TCR activation andmaintenance of
CD8ab expression and sustained TCR signals (needed for acti-
vation-induced CD8aa) and the generation of effector cells and
effector-based memory precursor cells.
KAT6A now joins other histone acetyltransferases that modify
the Cd8 locus, such as Brd1/Hbo1, which, via acetylation of
H3K14, controls CD8 expression during thymic development
(Mishima et al., 2014). Collectively, our results suggest that mod-
ulationof the chromatin landscape in important regulatory regions
of the Cd8 locus dictates CD8 co-receptor levels and TCR
signaling intensity, thereby greatly influencing the lineage subset
diversity of the responding antiviral T cell pool. This regulatory
mechanism offers a promising target for immunomodulation to
direct the generation of specificmemory subsets or to alter T cells
that have become dysregulated or possess inappropriate TCR
reactivity.
EXPERIMENTAL PROCEDURES
Mice and Viral Infections
C57BL/6 (CD45.2), B6.SJL-PtprcaPep3b/BoyJ (B6.CD45.1), and C57BL/6 3
B6.CD45.1 (CD45.1+/CD45.2+ F1) were bred and maintained at the Walter
and Eliza Hall Institute. Kat6alox/lox mice (Voss et al., 2009) were crossed to
the Lck-Cre recombinase mouse strain (Hennet et al., 1995; Orban et al.,
1992) to induce T cell-specific homozygous deletion of Kat6a (Kat6alox/lox
Lck-Cre+)—otherwise designated as Kat6acKO mice (Figure S1A). Subsequent
backcrossing with P14 mice bearing the DbGP33-specific TCR (Pircher et al.,
1989) generated Kat6acKO P14 mice. E8I-deficient mice were previously
described (Ellmeier et al., 1998). Mice between 6 and 12 weeks of age were
used for experiments. Mice were infected with LCMV by intravenous injection
of 3 3 103 plaque-forming units (PFUs) of LCMV-WE strain. All animals were
maintained and bred under specific pathogen-free conditions and were
used in accordance with the guidelines of the Walter and Eliza Hall Institute
of Medical Research Animal Ethics Committee. E8I-deficient mice were bred
and maintained in the preclinical research facility of the Medical University of
Vienna. Animal husbandry and experimentation were performed under the na-
tional laws (Federal Ministry for Science and Research) and ethics committees
of the Medical University of Vienna and according to the guidelines of FELASA
(Federation of European Laboratory Animal Science Associations), which
match those of ARRIVE (Animal Research: Reporting of In Vivo Experiments).
Isolation of T Cells and Adoptive Transfers
CD8+ P14 T cells were isolated from the spleens and lymph nodes (LNs) of 6-
to 8-week-old CD45.2+ donor mice (WT P14 and Kat6acKO P14), using a nega-
tive-selection CD8a enrichment kit (Miltenyi Biotec). Purified naive CD8+Va2+
T cells (90% purity confirmed by flow cytometry) from separate WT and
Kat6acKO donor mice were adoptively transferred intravenously (i.v.) into unin-
fected CD45.1+/2+ F1 hosts (53 10
4 naive donor cells per recipient), and mice
were infected i.v. with LCMV-WE 24 hr later.
Cell-Surface Staining and Flow Cytometry
Single-cell suspensions were prepared from spleen, LNs (axillary, brachial,
inguinal, and mesenteric), or thymus using standard procedures. An allophy-
cocyanin (APC)-conjugated MHCI tetramer specific for the LCMV epitope
Db/GP33-41 purchased from Baylor College of Medicine or R-phycoerythrin
(PE)-conjugated MHCI dextramer purchased from Immudex was used to stain
cells for 1 hr at 4C prior to additional surface stains. Fluorochrome-labeled
monoclonal antibodies (mAbs) against CD8a (53-6.7), CD8b (H35-17.2), Va2
TCR chain (B20.1), TCRb (H57-597), CD4 (GK1.5), CD5 (53-7.3), CD44 (IM7),
CD127 (A7R34), KLRG-1 (2F1), CD45.1 (A20), and CD45.2 (104) were all
sourced from BD Pharmingen. Fluorescence intensities were measured using
a BD LSR II flow cytometer or BD LSR Fortessa (BD Biosciences), and data
were analyzed using Weasel flow cytometry (Walter and Eliza Hall Institute)
and FlowJo (Treestar) analysis software.
Chromatin Immunoprecipitation
Adoptively transferred congenically markedCD45.2+/CD45.1 donor cells iso-
lated from CD45.1+/CD45.2+ recipients 8 days post-infection were purified by
flow cytometry into KLRG-1low and KLRG-1high populations (fluorescence-
activated cell sorting [FACS]Aria, BD Biosciences). For chromatin immunopre-
cipitation (ChIP), between 1.0 3 106 and 4.0 3 106 cells from each population
were cross-linked with 1% paraformaldehyde (in PBS) and lysed in 1% SDS +
50 mM Tris-HCl + 10 mM EDTA + protease inhibitors. Cross-linked DNA was
sonicated (Branson Sonifier 250), and 20% of each sample was isolated to act
as a comparative input (discussed later). Remaining sonicated DNA was incu-
bated with anti-acetylated H3K9 Ab (antibody) (Millipore) overnight at 4C and
subsequently coupled with Protein G Dynabeads (Invitrogen) after an addi-
tional 4-hr incubation at 4C. Unbound chromatin was removed using a series
of four washes, and residual chromatin was subsequently eluted. Both elutedchromatin and comparative input were reverse cross-linked and immunopre-
cipitated with phenol/chloroform. Recovered DNA was resuspended in TE,
and enriched regions of the genome (relative to input) were measured by
real-time PCR using the primers described in Table S4.
RNA-Seq Analysis
For RNA-seq analysis, total RNA was prepared using a RNeasy Plus Mini Kit
(QIAGEN) according to the manufacturer’s instructions. Libraries were gener-
ated from RNA samples and sequenced at the Australian Genome Research
Facility using the Illumina HiSeq sequencing system. An average of 30 million
single-end 100 bp reads were obtained for each sample, split evenly over four
technical replicates. Reads were aligned to the mm10 build of the mouse
genome using Subread (Liao et al., 2013) with default parameters. Over 97%
of reads were successfully aligned in each sample. Technical replicates for
each sample were pooled into a single library. For each library, mapped reads
with a mapping quality score greater than or equal to 30 were assigned to
mouse genes in the NCBI RefSeq mouse annotation build 38 using feature-
Counts (Liao et al., 2014). An average of 74% of mapped reads was counted
into genes for each library.
Read counts for each gene were then used in a differential expression (DE)
analysis using the limma and edgeR packages (Liao et al., 2014; Robinson
et al., 2010; Smyth, 2004). Lowly expressed genes were first filtered out if
the average log-count per million (as computed by the aveLogCPM function)
was less than 0. Xist and any genes on the Y chromosome were also removed
to eliminate sex effects. Normalization was performed using the TMM
(trimmed mean of M values) method (Robinson and Oshlack, 2010) to remove
composition bias between libraries. Counts were then log-transformed using
the voom function (Law et al., 2014). A linear model was fitted to the log-counts
using the computed precision weights. Sample variances for each gene were
computed and shrunk toward a mean-variance trend using a robust empirical
Bayes strategy. For each contrast, a p value was computed for each gene us-
ing the treat function (McCarthy and Smyth, 2009), with aminimum fold change
of 1.1 in either direction. The Benjamini-Hochberg method was then applied to
control the false discovery rate (FDR). DE genes were defined as those that
were detected at an FDR of 5%.
MA plots were generated for each comparison by plotting the average log-
count per million against the shrunken log-fold change for each gene. Each
log-fold change was computed using the generalized linear model (GLM)
framework in edgeR with a prior count of 5. Genes that were significantly DE
in each comparison according to the previous treat analysis were colored.
In the ordering analysis, DE genes between the WT KLRG-1high, WT
KLRG-1low, and Kat6acKO KLRG-1high groups were detected at an FDR of 5%
using a one-way ANOVA with the voom and limma pipeline. These DE genes
were separated into three sets according to the ordering of the mean expres-
sion values in each group, e.g., theWTKLRG-1 set contains all DEgeneswhere
the mean expression value for WT KLRG-1 lies between the mean expression
values of the other two groups. If all groups are equally dissimilar, each set
should be of equal size and contain a third of all DE genes. The statistical sig-
nificance of any overrepresentation for a given set was tested by computing
a p value for a one-sided binomial test, conditioning on the total number of
DE genes (and assuming independence between genes). This was repeated
for the WT KLRG-1high, WT KLRG-1low, and Kat6acKO KLRG-1low groups.
Statistics
A Student’s t test (unpaired or paired) was performed to determine statistical
significance unless indicated otherwise. Proportional data were arc sine trans-
formed prior to analysis. Error bars denote mean ± SEM.
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